Janice Brunetti

Author PubWeight™ 0.85^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer.	Clin Cancer Res	2007	0.88